Friday - May 01, 2026

Category Archives: Science

RNA Therapies Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “RNA Interference Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 90+ pipeline drugs in the RNA Interference pipeline landscape. It covers the RNA Interference pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Optical Coatings Market Advances Steadily to 237 Million Square Meters by 2033, Driven by Solar Energy Expansion and Next-Generation Electronics Demand

Optical Coatings Market From photovoltaic panels to precision aerospace optics, optical coatings are quietly powering some of the most critical technological transitions of this decade. The Global Optical Coatings Industry is expanding at a measured but structurally well-supported pace. The … Continue reading →

Major Depressive Disorder Treatment Pipeline Shows Strong Momentum as 75+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Major Depressive Disorder Pipeline Insight 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Sarcopenia Clinical Trial Pipeline Expands as 18+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Sarcopenia Pipeline Insight 2026” report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Sarcopenia pipeline landscape. It covers the Sarcopenia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Sarcopenia therapeutics … Continue reading →

Dengue Clinical Trial Pipeline Shows Potential with Active Contributions from 20+ Key Companies | DelveInsight

DelveInsight’s, “Dengue Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Dengue pipeline landscape. It covers the Dengue pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Dengue therapeutics assessment … Continue reading →

Generalized Myasthenia Gravis Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Generalized Myasthenia Gravis Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Generalized Myasthenia Gravis (gMG) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Sjögren’s Disease Clinical Trial Pipeline Gains Momentum: 20+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Sjogren’s Syndrome Pipeline Insight 2026” report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Sjogren’s Syndrome pipeline landscape. It covers the Sjogren’s Syndrome pipeline drugs profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

International Chemical Industry Fair (ICIF) 2026 Set to Redefine Global Chemical Procurement Behavior at Shanghai New International Expo Centre, September 15-17, 2026

International Chemical Industry Fair — ICIF ICIF 2026, held September 15–17 at SNIEC Shanghai, positions itself as a global hub for petrochemical industry events, chemical raw materials procurement, and digital transformation solutions. Bringing 2,218 exhibitors and 80,000 buyers, the event … Continue reading →